Pill vs. injection: new hope for kids with Kidney-Related anemia

NCT ID NCT05970172

Recruiting now Disease control Sponsor: Astellas Pharma Global Development, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing an oral pill called roxadustat as a potential new treatment for anemia (low red blood cells) in children and teenagers with chronic kidney disease. The goal is to see if this pill, taken three times a week for up to a year, is a safe and effective alternative to the current standard treatment, which involves regular injections. Researchers will monitor the children's blood levels and overall health closely throughout the study.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Site BE32001
RECRUITING

Edegem, Belgium
Site BE32002
RECRUITING

Brussels, Belgium
Site BE32003
RECRUITING

Leuven, Belgium
Site BE32004
RECRUITING

Ghent, Belgium
Site BG35901
RECRUITING

Sofia, Bulgaria
Site CZ42001
RECRUITING

Prague, Czechia
Site CZ42002
RECRUITING

Brno, Czechia
Site DE49001
RECRUITING

Tübingen, Germany
Site DK45001
RECRUITING

Aarhus, 8200, Denmark
Site ES34003
RECRUITING

Esplugues de Llobregat, Spain
Site FI35801
RECRUITING

Helsinki, Finland
Site GB44001
RECRUITING

Nottingham, United Kingdom
Site GB44003
RECRUITING

Newcastle upon Tyne, United Kingdom
Site GB44004
RECRUITING

Southampton, United Kingdom
Site GB44005
RECRUITING

Cardiff, United Kingdom
Site GB44006
RECRUITING

Glasgow, United Kingdom
Site GB44007
RECRUITING

London, United Kingdom
Site GB44008
RECRUITING

Liverpool, United Kingdom
Site GR30001
RECRUITING

Thessaloniki, Greece
Site GR30002
RECRUITING

Athens, Greece
Site HR38501
RECRUITING

Zagreb, Croatia
Site HR38503
RECRUITING

Zagreb, Croatia
Site IE35301
RECRUITING

Dublin, Ireland
Site IT39003
RECRUITING

Milan, Italy
Site IT39004
RECRUITING

Padua, Italy
Site LB96101
RECRUITING

El Achrafiyé, Lebanon
Site LT37001
RECRUITING

Vilnius, Lithuania
Site NL31002
RECRUITING

Rotterdam, Netherlands
Site NO47002
RECRUITING

Oslo, Norway
Site PL48002
RECRUITING

Warsaw, Poland
Site PL48003
RECRUITING

Krakow, Poland
Site RO40001
RECRUITING

Timișoara, 30011, Romania
Site RO40002
RECRUITING

Clug Napoca, 400370, Romania
Site SA96601
RECRUITING

Riyadh, Saudi Arabia
Site SA96602
RECRUITING

Dammam, Saudi Arabia
Site SE46002
RECRUITING

Mölnlycke, Sweden
Site SE46003
RECRUITING

Mölnlycke, Sweden
Site SK42101
RECRUITING

Bratislava, Slovakia
Site SP34001
RECRUITING

Madrid, 28041, Spain
Site TR90001
RECRUITING

Ankara, Turkey (Türkiye)
Site TR90002
RECRUITING

Manisa, Turkey (Türkiye)
Site TR90003
RECRUITING

Istanbul, Turkey (Türkiye)
Site TR90005
RECRUITING

İzmit, Turkey (Türkiye)
Site TR90006
RECRUITING

Kayseri, Turkey (Türkiye)
Site TR90007
RECRUITING

Ankara, Turkey (Türkiye)
Site TR90008
RECRUITING

Istanbul, Turkey (Türkiye)
Site TR90010
RECRUITING

Ankara, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.

CHRONIC KIDNEY DISEASE RENAL ANEMIA